A CDC report warned this week that the ongoing Ebola outbreak spanning the Democratic Republic of Congo and Uganda could become one of the worst on record unless the world acts swiftly. The alarm follows WHO director-general’s statement that the outbreak may have begun as early as January — suggesting months of undetected spread before international health bodies sounded public alarms. Compounding the crisis, rebel attacks in eastern DRC by the Allied Democratic Forces have killed at least 30 people and are actively hampering the Ebola response — preventing health workers from reaching affected communities and disrupting the cold chain logistics required for vaccine delivery. Simultaneously, experts are criticising a plan for an American-only Ebola quarantine facility in Kenya, which they say reflects donor-country insularity rather than outbreak containment logic.
The received wisdom
Global health professionals broadly agree on what the correct response looks like: surge funding to WHO and the DRC Ministry of Health, accelerate ring vaccination with the rVSV-ZEBOV vaccine (which proved effective in the 2018-2020 DRC outbreak), establish a ceasefire corridor in the conflict zones of North Kivu and Ituri, and coordinate with Uganda’s health system given cross-border transmission. The international humanitarian complex — Médecins Sans Frontières, CDC, USAID, GAVI — has the institutional memory and the technical capacity to execute this response. What is required is political will and money, both of which have historically materialised when wealthy countries perceive a direct threat to themselves.
The received wisdom also holds that the current situation, while serious, is manageable given the right mobilisation. Africa has developed substantial indigenous Ebola-response capacity since the 2014-2016 West Africa outbreak, the largest in history. The DRC has been through Ebola before — this is at least its fourteenth outbreak. The tools exist; the bottleneck is logistics and insecurity, not knowledge.
A different read
The received wisdom is technically accurate but politically evasive. It consistently frames each new outbreak as a mobilisation problem — we know what to do, we just need the will — without confronting the structural reasons why the will keeps arriving late, incompletely, and attached to conditions that serve donor interests more than outbreak containment.
Consider the timeline. The WHO chief now says the outbreak may have started in January. It is now June. If that five-month detection lag is accurate, it represents a catastrophic failure of the surveillance systems that rich countries fund, praise, and consider proof that “we learned from 2014.” The 2014 West Africa outbreak — which killed over 11,000 people — also began months before international bodies acknowledged its scale. The lesson, apparently, has not been learned in any operationally meaningful sense.
The rebel attacks hampering the response are not incidental; they are structural. Eastern DRC has been in a state of low-grade armed conflict for three decades, a conflict that is, in part, a product of competition over mineral resources that supply the global technology supply chain — coltan, cobalt, lithium. The same international economic order that provides the devices on which you are reading this piece is implicated in the political economy that keeps eastern DRC ungovernable. A serious global health governance framework would treat conflict resolution in eastern DRC as a prerequisite for outbreak containment, not a separate problem for a different department.
The American-only quarantine facility criticism is particularly revealing. Experts told the Guardian that the facility’s design reflects political accountability to American voters rather than epidemiological effectiveness. This is the logic of every wealthy country’s global health posture: we fund interventions that protect our populations and can be presented domestically as responsible stewardship, not interventions that would most effectively prevent outbreaks from spreading. Ring vaccination in North Kivu is cheap and effective but hard to explain to a congressional appropriations committee. A gleaming US-run facility in Nairobi is expensive and marginal but photographs well.
The pattern is not new. William Foege, the CDC director who designed the smallpox eradication strategy, argued in his memoir that the key insight of eradication campaigns is that you must go where the disease is, not where the infrastructure already exists. Every major outbreak since 2000 — SARS, H1N1, MERS, West Africa Ebola, COVID-19 — has been followed by institutional reviews that identify the same gaps: surveillance latency, supply chain fragility, conflict-zone access, underfunding of local health systems. And then, after the acute phase passes, the funding dries up and the gaps reopen.
The CDC’s warning that this outbreak could “rival the worst on record” is a bureaucratic alarm, delivered in bureaucratic language. What it actually means is that the architecture of neglect built into international health governance has, again, allowed a preventable catastrophe to reach a scale at which it will become expensive to contain.
What to watch
Whether a ceasefire corridor can be negotiated with ADF or other armed groups in eastern DRC specifically for health worker access. Past outbreaks suggest this is possible but requires sustained diplomatic attention from regional powers — particularly Uganda, Rwanda, and Angola — rather than distant condemnation.
Vaccine supply availability: the rVSV-ZEBOV stockpile is finite. If the outbreak spreads to multiple simultaneous clusters, allocation decisions will become politically fraught, and the appearance of favouring certain communities over others can itself generate resistance to vaccination.
Cross-border spread to Uganda and beyond: Kampala is a regional transport hub. If community transmission reaches urban Uganda, the containment calculus changes dramatically, and the risk of international spread via air travel increases.
Donor funding response speed: the historical pattern is two to four months of delay before major funding tranches are approved. In a fast-moving outbreak, that delay is itself a policy choice — with consequences measured in lives.
— J